Alterity Therapeutics Phase 2 Data Monitoring Committee
ATH434-201 Trial on Track to Complete Enrollment in Q3 2023 Top-Line Data Expected by the End of 2024 MELBOURNE, Australia and SAN FRANCISCO, July 26,...
Source: globenewswire.com
Page 5 - System Atrophy News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from System Atrophy. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In System Atrophy Today - Breaking & Trending Today
Alterity Therapeutics Phase 2 Data Monitoring Committee Recommends Continuing Clinical Trial as Planned
ATH434-201 Trial on Track to Complete Enrollment in Q3 2023 Top-Line Data Expected by the End of 2024 MELBOURNE, Australia and SAN FRANCISCO, July 26, 2023 -- Alterity Therapeutics , a...
Source: marketscreener.com
Family stages charity run in memory of Cockfield mum | Darlington and Stockton Times
A family is organising a charity fun run in memory of a much-loved County Durham mum-of-two.
Source: darlingtonandstocktontimes.co.uk
Alterity Therapeutics Initiates Second Phase 2 Study in Rare Parkinsonian Disorder
- ATH434 now being evaluated in early and more advanced Multiple System Atrophy - - New trial expected to generate data before ongoing Phase 2 trial - MELBOURNE, Australia and SAN FRANCISCO, May... | May 30, 2023
Source: marketscreener.com
Alterity Therapeutics Enrolls First Patient in Australia in
MELBOURNE, Australia and SAN FRANCISCO, May 10, 2023 (GLOBE NEWSWIRE) -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) (“Alterity” or “the Company”), a...
Source: globenewswire.com